Esperion Therapeutics, Inc. (NASDAQ:ESPR) Position Boosted by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD lifted its position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 15.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 123,896 shares of the biopharmaceutical company’s stock after buying an additional 16,404 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Esperion Therapeutics […]
Price T Rowe Associates Inc. MD lifted its position in Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) by 15.3% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 123,896 shares of the biopharmaceutical company’s stock after buying an additional 16,404 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in Esperion Therapeutics […]
